Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07398651
NA

Apremilast and Adalimumab in Psoriatic Arthritis Patients

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

The aim of this work is to compare the efficacy of Apremilast combined with Methotrexate versus Adalimumab combined with Methotrexate

Official title: Comparative Study Between Apremilast and Adalimumab in Psoriatic Arthritis Patients

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-12-30

Completion Date

2026-12-30

Last Updated

2026-02-10

Healthy Volunteers

No

Interventions

DRUG

Adalimumab

PsA patients who will receive Adalimumab with methotrexate therapy for 3 months

DRUG

Apremilast

PsA patients who will receive Apremilast with methotrexate therapy for 3 months

Locations (1)

Tanta University

Tanta, Egypt